Alcántara-Aragón Valeria
Endocrinology and Nutrition Department, Hospital de la Santa Creu I Sant Pau, Sant Antoni Maria Claret 167, Barcelona, 08025, Spain.
Ther Adv Endocrinol Metab. 2019 Jan 28;10:2042018818824215. doi: 10.1177/2042018818824215. eCollection 2019.
Diabetes technologies are an unstoppable phenomenon. They offer opportunities to improve patient self-care through empowerment. However, they can be a challenge for both patients and clinicians. Thus, the use of technology may empower or burden. To understand and benefit from the use of diabetes technologies, one must understand the currently unmet needs in diabetes management. These unmet needs call for perspectives beyond glycated hemoglobin and an evaluation of technology solutions. Optimal use of these technologies is necessary to obtain benefits and achieve cost-effectiveness; this process depends on diabetes education and training. This review evaluates clinician and patient perspectives regarding diabetes technologies, followed by an evaluation of technology solutions. Diabetes technology solutions are evaluated according to available results about their effectiveness and their potential to empower people living with diabetes.
糖尿病技术是一种不可阻挡的现象。它们通过赋予患者自主权，为改善患者自我护理提供了机会。然而，它们对患者和临床医生而言都可能是一项挑战。因此，技术的使用可能会赋予力量，也可能带来负担。为了理解并从糖尿病技术的使用中获益，必须了解糖尿病管理中目前尚未满足的需求。这些未满足的需求需要超越糖化血红蛋白的视角，并对技术解决方案进行评估。最佳地使用这些技术对于获得益处和实现成本效益是必要的；这个过程依赖于糖尿病教育与培训。本综述评估了临床医生和患者对糖尿病技术的看法，随后对技术解决方案进行了评估。糖尿病技术解决方案根据其有效性以及增强糖尿病患者能力的潜力的现有结果进行评估。
